|Bid||19.95 x 1100|
|Ask||19.98 x 800|
|Day's range||19.39 - 20.25|
|52-week range||9.26 - 29.59|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||N/A|
|Earnings date||26 Feb 2024 - 01 Mar 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.00|
Last week, Castle Biosciences, Inc. ( NASDAQ:CSTL ) insiders, who had purchased shares in the previous 12 months were...
FRIENDSWOOD, Texas, November 14, 2023--Castle announced that data spanning its dermatologic portfolio of GEP tests was recently presented at the 2023 ASDS Annual Meeting.
FRIENDSWOOD, Texas, November 13, 2023--Castle Biosciences has been named a Houston Chronicle Top Workplace for the third year in a row.